Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Flavonoid intakes inversely associate with COPD in smokers

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Neonatal metabolome of caesarean section and risk of childhood asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. ERS Statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. The developing airway and gut microbiota in early life is influenced by age of older siblings

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Height and bone mineral content after inhaled corticosteroid use in the first 6 years of life

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Neonatal metabolome of caesarean section and risk of childhood asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

BACKGROUND: Harmful effects of prenatal tobacco exposure and possible interaction with 17q12-21 genetic variants have been shown for some asthma outcomes in childhood, whereas findings related to allergy outcomes are more inconsistent. This study aimed to examine the effect of prenatal tobacco exposure and relation to 17q12-21 genotype on a wide array of asthma and allergy-related outcomes in early childhood.

METHODS: Prenatal tobacco exposure was determined by maternal smoking during the third trimester (yes/no) in 411 children from the phenotyped Copenhagen Prospective Studies on Asthma in Childhood 2000 (COPSAC2000) birth cohort with clinical follow-up to age 7 years. The rs7216389 single nucleotide polymorphism was used as main representative of the 17q12-21 locus. Asthma end-points included asthma diagnosis, exacerbations, episodes with troublesome lung symptoms and lower respiratory tract infections, spirometry, plethysmography, bronchial responsiveness to methacholine, exercise and cold dry air. Allergy-related endpoints included aeroallergen sensitisation, allergic rhinitis, fractional exhaled nitric oxide, blood eosinophil count and urine eosinophil protein X levels. Statistical analyses were done using Cox regression, linear regression, logistic regression and quasi-Poisson regression.

RESULTS: Prenatal tobacco exposure increased the risk of asthma (adjusted hazard ratio (aHR) 2.05, 95% CI 1.13-3.73; p=0.02), exacerbations (aHR 3.76, 95% CI 2.05-6.91; p<0.001), number of LRTIs (adjusted incidence rate ratio 1.87, 95% CI 1.34-2.55; p<0.001), and was associated with decreased spirometry indices (forced expiratory volume in 1 s (FEV1) adjusted mean difference (aMD) -0.07 L, 95% CI -0.13- -0.005 L, p=0.03; maximal mid-expiratory flow aMD -0.19 L·s-1, -0.34- -0.04 L·s-1, p=0.01) and increased bronchial responsiveness to methacholine (provocative dose of methacholine causing a 20% drop in FEV1 adjusted geometric mean ratio 0.55, 95% CI 0.31-0.96; p=0.04). In contrast, there was no association with any allergy-related end-points. The effect on asthma depended on 17q12-21 genotype with an increased risk only among children without risk alleles.

CONCLUSION: Prenatal tobacco exposure was associated with asthma dependent on 17q12-21 genotype and with exacerbations, lung function and bronchial responsiveness, but not with any allergy-related outcomes. This suggests that tobacco exposure in utero leads to adverse lung developmental/structural effects rather than susceptibility to develop allergy and type 2 inflammation.

OriginalsprogEngelsk
Artikelnummer2100453
TidsskriftThe European respiratory journal
Vol/bind59
Udgave nummer2
ISSN0903-1936
DOI
StatusUdgivet - feb. 2022

Bibliografisk note

Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org.

ID: 74542054